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Pyruvate dehydrogenase kinaseGlucose-induced insulin secretion from pancreatic β-cells depends onmitochondrial activation. In the organelle,
glucose-derived pyruvate is metabolised along the oxidative and anaplerotic pathway to generate downstream
signals leading to insulin granule exocytosis. Entry into the oxidative pathway is catalysed by pyruvate dehydro-
genase (PDH) and controlled in part by phosphorylation of the PDH E1α subunit blocking enzyme activity. We
ﬁnd that glucose but not other nutrient secretagogues induce PDH E1α phosphorylation in INS-1E cells and
rat islets. INS-1E cells and primary β-cells express pyruvate dehydrogenase kinase (PDK) 1, 2 and 3, which me-
diate the observed phosphorylation. In INS-1E cells, suppression of the two main isoforms, PDK1 and PDK3,
almost completely prevented PDH E1α phosphorylation. Under basal glucose conditions, phosphorylation was
barely detectable and therefore the enzyme almost fully active (90% of maximal). During glucose stimulation,
PDH is only partially inhibited (to 78% of maximal). Preventing PDH phosphorylation in situ after suppression
of PDK1, 2 and 3 neither enhanced pyruvate oxidation nor insulin secretion. In conclusion, although glucose
stimulates E1α phosphorylation and therefore inhibits PDH activity, this control mechanism by itself does not
alter metabolism-secretion coupling in INS-1E clonal β-cells.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Pancreatic β-cells adapt insulin secretion to changes in plasma
nutrient concentrations. The exocytosis of insulin granules, the main
function of this cell type, is induced by the uptake and metabolism
of nutrient secretagogues. Mitochondria are a key organelle for nutri-
ent metabolism and a source of signals that directly inﬂuence β-cell
secretory function [1,2]. This is achieved in part through the oxidation
of nutrients in the mitochondrial matrix, which provides reducing
equivalents serving as substrate for oxidative phosphorylation. The
associated activation of respiration promotes the synthesis and
export of ATP from mitochondria. The resulting increase of the
cytosolic ATP/ADP ratio favors closure of KATP channels. This leads to
depolarization of the plasma membrane and thereby induces β-cell
electrical activity (triggering pathway of insulin secretion). In
addition, anaplerosis in β-cell mitochondria is able to increase the
pool of TCA cycle intermediates several of which are exported to theell Physiology and Metabolism,
neva 4, Switzerland. Tel.: +41
tion Research, Nestlé Institute of
ausanne, Switzerland. Tel.: +41
llheim),
rights reserved.cytosol where they may act as signals amplifying the insulin secretory
response (amplifying pathway) [2,3].
Glucose-derived pyruvate is efﬁciently taken up by β-cell mitochon-
dria presumably via the recently identiﬁed pyruvate carrier [4]. In themi-
tochondrial matrix pyruvate is oxidised by pyruvate dehydrogenase
(PDH) to form acetyl-CoA. Alternatively pyruvate enters the anaplerotic
pathway initiated by pyruvate carboxylase (PC). In the β-cell, both
pathways are used about equally [5–7]. Interestingly, followingdisruption
of the pyruvate dehydrogenase gene (Pdha1) in β-cells, glucose-
stimulated insulin secretion (GSIS) was impaired but not abolished [8].
These results demonstrate that GSIS does not solely rely onmitochondrial
pyruvate oxidation. These ﬁndings are consistent with the view that me-
tabolite ﬂuxes through both PDH and PC are important for insulin secre-
tion [9,10]. Interfering with PC function reduces anaplerosis required for
the cycling of metabolites across the inner mitochondrial membrane
and lowers the cellular ATP/ADP ratio, therefore inhibiting GSIS [9–13].
In the β-cell, the relative use of the oxidative and anaplerotic path-
ways of mitochondrial pyruvate metabolism must be controlled and ad-
justed to the nutrient conditions. Indeed, anaplerosis of glucose-derived
carbons increases as the glucose concentration rises [7,10]. Several impor-
tant control mechanisms are decisive for the relative ﬂux through PDH
and PC. For instance elevation of the NADH/NAD+, acetylCoA/CoA or
ATP/ADP ratios is inhibitory for PDH enzyme activity. Reversible phos-
phorylation is another mechanism controlling PDH activity. Pyruvate de-
hydrogenase kinases (PDK) phosphorylate PDH E1α, thereby almost
completely inhibiting enzyme activity [14–16]. PDKs phosphorylate the
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leading to the inactivation of the PDH complex (for review see [14–16]).
Four PDK isoforms have been identiﬁed in mammalian tissues, several
of which are expressed in pancreatic islets [17,18].
Dephosphorylation of E1α and, as a consequence, reactivation of
PDH is catalysed by pyruvate dehydrogenase phosphatases (PDP) 1 or
2. Both phosphatases require Mg2+ while only PDP1 is activated by
Ca2+ [19]. In the pancreatic β-cell, mitochondrial Ca2+ rises transiently
shortly after nutrient stimulation and is an essential signal for the ampli-
ﬁcation of insulin secretion [20]. Mitochondrial Ca2+ could exert its
signaling role at least in part through the activation of PDP1-mediated
dephosphorylation of PDH.
Todate, there is no consensus as to the activity of PDHunder resting or
nutrient-stimulated conditions in the pancreatic β-cell. While some
studies ﬁnd very low activity (b10%) under resting conditions and strong
glucose-induced activation, other results describe constitutively high PDH
activity (up to 94% of total) [18,21–23]. In addition to the still debated
acute effect of glucose, chronic incubation of islets in high glucose or pal-
mitate inhibits PDH due to increased PDK activity in the islets [18,24]. It is
of interest, in this context, that glucose which promotes activation of
hypoxia-inducible factor 1α (HIF1α) in islets by lowering intracellular
oxygen tension also up regulates PDK1 expression [25].
Over-expression of either PDKs or PDPs has been used as an
approach to assess the relevance of PDH phosphorylation as a
regulatory mechanism during nutrient-stimulated insulin secretion.
Over-expression of PDK3 or PDK4 clearly reduced PDH activity without
lowering GSIS in rat islets or INS-1 cells [12,23]. Reducing PDH activity
therefore does not appear sufﬁcient to impair metabolism-secretion
coupling. On the other hand, expressing a catalytically active form of
PDP elevated PDH activity but failed to alter GSIS in rat islets [23]. In
contrast to these negative ﬁndings, a recent study has observed
enhanced GSIS after selective knockdown of PDK1 in INS-1 832/13 clon-
alβ-cells [26]. PDK1 knockdown raised PDH activity, mitochondrial res-
piration and by favoring anaplerosis several intermediates of the TCA
cycle.
Here we examined the expression of the different PDK isoforms as
well as PDH phosphorylation in INS-1E and primary β-cells. We also
studied whether PDH E1α phosphorylation exerts a control function
in GSIS following knockdown of the different PDK isoforms expressed
in INS-1E cells.
2. Materials and methods
2.1. Reagents
Chemicals were from either Sigma or Fluka (Buchs, Switzerland)
unless otherwise indicated.
2.2. Preparation and culture of rat islets and FACS-puriﬁed α- and β-cells
Animal care and experimentation were conducted according to
the guidelines of the Swiss Academy of Medical Sciences and
performed with the permission of the Canton of Geneva Veterinary
Ofﬁce. Rat islet isolation and puriﬁcation of islet cells were carried
out as described previously [27].Table 1
Primers used for quantitative RT-PCR. Sequences shown are 5′→3′.
Gene name Forward primer
Cyclophilin CGT GGG CTC CGT TGT CTT
RPS-29 GGT CGC TTA GTC CAA CTT AAT GA
PDK1 CGG TGC CCC TGG CTG GAT TT
PDK2 GCT GTC CAT GAA GCA GTT TCT AG
PDK3 TGA CCT AGG TGG TGG AGT CCC A
PDK4 TCT AAC GTC GCC AGA ATT AAA GC2.3. Cell culture conditions
INS-1E cells [28]were cultured at 37 °C in humidiﬁed atmosphere (5%
CO2) in RPMI-1640 medium containing 11 mM glucose (Invitrogen),
supplemented with 10 mM Hepes, 5% (v/v) heat-inactivated fetal calf
serum (Brunschwig AG, Switzerland), 1 mM sodium pyruvate, 50 μM
β-mercaptoethanol, 50 μg/ml penicillin and 100 μg/ml streptomycin
(INS medium). Most experiments were performed in Krebs–Ringer
bicarbonate Hepes buffer (KRBH): 140 mM NaCl, 3.6 mM KCl, 0.5 mM
NaH2PO4, 0.5 mM MgSO4, 1.5 mM CaCl2, 10 mM Hepes, 5 mM NaHCO3,
pH 7.4.
2.4. Analysis of gene expression
Total RNA was extracted using RNeasy Mini Kit (Qiagen). Samples
were treated with 0.5 U of RNase-free DNase I (Ambion, Austin, TX,
USA)/1 μg of RNA. Single-stranded DNA was synthesised employing
SuperScript™ II reverse transcriptase (Invitrogen) and random
hexamer primers (Invitrogen). Single-stranded DNA was used as a
template in quantitative PCR using FastStart Universal SYBR Green
mix (Roche Diagnostics GmbH, Mannheim, Germany) and speciﬁc
primer pairs (Table 1). The results were analysed using ABI PRISM
7000 SDS software (Applied Biosystems, Foster City, CA, USA).
Expression levels were calculated according to the Pfafﬂmethod [29].
2.5. siRNA transfection
INS-1E cells were plated in antibiotic-free INS medium and
transfected the next day with 30 nM siRNA and 1.4 μl/ml DharmaFECT
1 transfection reagent (Thermo Fisher Scientiﬁc, Lafayette, CO, USA).
24 h after transfection the medium was changed to regular INS medi-
um. Quantitative RT-PCRwas performed 96 h post-transfection. siRNAs
were purchased from Ambion (Austin, TX, USA). siRNA sense strand
sequences (5′→3′) are: PDK1: GAA CUG UUC AAG AAC GCA ATT;
PDK2: AGA ACA UCC AGU ACU UUU UTT; PDK3: GAU CCA CGC GUU
UUA GAU ATT; negative control siRNA #2 (Ambion).
2.6. Cell lysate preparation and Western blotting
INS-1E cells were washed once with ice-cold PBS without Ca2+ and
Mg2+, harvested, extracted using lysis buffer (20 mM Tris–HCl, 2 mM
EDTA, 2 mM EGTA, 0.5 mM PMSF, 10 mM NaF, 0.04% (v/v)
β-mercaptoethanol, 1% (v/v) Triton X-100) and sonicated. Protein
samples were separated on 10% SDS polyacrylamide gels and trans-
ferred to Hybond-ECL membranes (Amersham Biosciences).
Membranes were blocked in 4% fat-free powdered milk in TBS-T
(25 mM Tris, 150 mM NaCl, 2.68 mM KCl, 0.1% (v/v) Tween-20, pH
7.4) for 50 min at room temperature and incubated at 4 °C overnight
with a sheep polyclonal antibody against PDHE1α subunit phosphorylat-
ed on site 1 (Ser293) or site 2 (Ser300) (1 μg/ml in 3% milk in TBS-T).
Secondary antibody: HRP-labeled anti-sheep antibody (DakoCytomation,
Glostrup, Denmark; 0.43 μg/ml in 3%milk in TBS-T). Bandswere detected
using ECL chemiluminescent system (AmershamBiosciences). Themem-
braneswere re-probed using an antibody recognizing PDH E1α. The PDH
antibodies [30] were kindly provided by Dr. H. Pilegaard (University of
Copenhagen, Denmark).Reverse primer
TGA CTT TAG GTC CCT TCT TCT TAT CG
A G GCT GAA CAT GTG CCG ACA GT
GCA TCC GTC CCG TAG CCC TC
A CGG AGG AAG GTG AAT GAA GTT TT
ACC AAA TCC AGC CAA GGG AGC A
GAA CGT ACA CGA TGT GGA TTG G
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Fig. 1. Acute glucose-dependent PDH E1α phosphorylation in INS-1E cells and rat pancreatic
islets. (A) INS-1E cellswere preincubated for 30 min inKRBH containing 2.5 mMglucose and
stimulated with 16.7 mM glucose for the indicated time. Cell lysates (50 μg) were analysed
by Western blotting using an antibody speciﬁcally recognizing site 1 phosphorylated PDH
E1α (p-Ser293) (upper panel) and re-probed with an antibody raised against PDH E1α
(lower panel). (B, C) INS-1E cells were preincubated as described in A and stimulated for
15 min with increasing concentrations of glucose as shown in the ﬁgure. An antibody recog-
nizing site 1 phosphorylated PDH E1α (p-Ser293) (B) or site 2 phosphorylated PDH E1α
(p-Ser300) (C) was used (upper panels). (D) Rat islets were preincubated for 30 min in
KRBH containing 2.5 mM glucose, then incubated for 15 min with KRBH containing 2.5 or
16.7 mM glucose. Islet lysates (50 μg) were analysed as described in (A).
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PDH activity was measured using a PDH enzyme assay kit
(MitoSciences, Eugene, OR, USA) according to the manufacturer's
protocol with the following modiﬁcations. During cell lysis and PDH
immunocapture: 1 mM PMSF, protease inhibitor cocktail (Roche
Diagnostics GmbH, Mannheim, Germany), 1 mM EDTA, 20 mM NaF,
5 mM DCA was included. 1 mg of total cell lysate was loaded per
anti-PDH antibody coated microtiter well. Enzyme activity was
followed for 1 h at 25 °C on a FLUOstar OPTIMA microplate reader
(BMG Labtechnologies, Offenburg, Germany). To determine the
maximal activity of fully-dephosphorylated PDH, parallel samples
were treated with pyruvate dehydrogenase phosphatase PDP1
(MitoSciences, Eugene, OR, USA).
2.8. [1-14C] pyruvate oxidation measurements
INS-1E cells were plated in 6-well tissue culture plates (Becton
Dickinson, Franklin Lakes, NJ, USA) at a density of 0.5×106 cells/well
and grown for 48 h. Cells were switched for 2 h to RPMI-1640medium
containing 4 mMglucose and 1% (v/v) FCS. The cells were washed once
with KRBH 2.5 mM glucose and preincubated in the same buffer for
30 min. Labeling was performed for 1 h in KRBH containing 2.5 or
16.7 mM glucose plus 0.1 mM cold pyruvate and 0.02 nCi/μl of [1-14C]
pyruvate (American Radiolabeled Chemicals). During the incubation
14CO2 was captured with NaOH-soaked Whatman ﬁlters. To extract
14CO2 from the medium 5 M HCl was injected. The captured 14C on
ﬁlters was counted in scintillation vials (Wheaton, Millville, NJ, USA).
The scintillation ﬂuid was from Packard (USA).
2.9. Cell death assays
Relative changes in cell death in INS-1E cell populations were
measured using a Cell Death Detection ELISAPLUS kit (Roche Diagnos-
tics GmbH, Mannheim, Germany). The percentage of apoptotic plus
necrotic cells was determined using propidium iodide. Cells were in-
cubated in KRBH buffer containing 5 μg/ml propidium iodide for
20 min at 37 °C. The nuclei of all cells in the culture were then stained
with Hoechst 33342 dye (5 µg/ml) for 5 min at room temperature.
Fluorescence pictures were taken to calculate the percentage of
propidium iodide positive per total Hoechst stained nuclei. For each
condition more than 6000 cells were analysed.
2.10. Insulin secretion assay
INS-1E cells were plated into polyornithin-coated 24-well tissue
culture plates (Becton Dickinson, Franklin Lakes, NJ, USA) at a density
of 7.5×104 cells/well. The day after plating, cells were transfected
with siRNAs. Secretion assays were performed 96 h later. Static insu-
lin secretion assays and insulin measurements were carried out as de-
scribed previously [31].
2.11. Mitochondrial Ca2+ measurements
INS-1E cells (7.5×104 cells) were plated on polyornithin-treated
15 mm diameter Thermanox coverslips (Nalge Nunc, Rochester, NY,
USA) in 4-well tissue culture plates. The day after plating, cells were
transfected with siRNAs. 48 h post-transfection cells were infected for
2 h with adenovirus expressing mitochondrially-targeted aequorin
under the control of the rat insulin promoter (Ad-RIP-mitoAequorin).
96 h post-transfection cells were transferred for 2 h to RPMI-1640
medium containing 4 mMglucose, 1% (v/v) FCS and 5 μMcoelenterazine
(Calbiochem). INS-1E cell perifusions and analysis of the mitoAequorin
signal were carried out as described previously [20].3. Results
3.1. Glucose stimulates PDH E1α phosphorylation in INS-1E cells and rat
pancreatic islets
Enhanced mitochondrial oxidative metabolism following glucose
stimulation of the pancreatic β-cell could in part be due to
Ca2+-dependent dephosphorylation causing activation of PDH
[22,32]. To test this possibility, we followed PDH phosphorylation in
β-cells during acute glucose stimulation by Western blotting using
an antibody speciﬁcally recognizing Ser293 (site 1) phosphorylated
PDH E1α [30]. Only a faint band was detected in lysates prepared
from INS-1E cells maintained at resting glucose concentrations
(2.5 mM) suggesting that only a small fraction of total PDH is phos-
phorylated. Within 2 min following stimulation with 16.7 mM glu-
cose, PDH E1α phosphorylation was markedly increased. Thereafter
phosphorylation augmented further and remained elevated in the
continued presence of glucose (Fig. 1A; up to 30 min). Over the
time-course studied total PDH E1α protein levels on the other hand
remained constant.
The minimal glucose concentration required for PDH E1α phos-
phorylation was 7.5 mM (Fig. 1B). Glucose-dependent phosphoryla-
tion was also observed on phosphorylation site 2 of PDH E1α as
detected using an antibody speciﬁcally recognizing phosphorylated
E1α (Ser300) (Fig. 1C). The concentration required to induce phos-
phorylation of PDH suggests that this posttranslational modiﬁcation
AC
D
16.7 + KCl
16.7
EGTA
PDH E1α-
p-Ser 293
total
glc, mM:  2.5    16.7        2.5 + 10 mM leucine
total
p-Ser 293
PDH E1α-
min:   15        5       10      20       30       15
glc, mM:  2.5    2.5 + 5 mM mm-succinate   16.7
PDH E1α-
p-Ser 293
total
min:  15       15        2         5       10      15       20        30  
glc, mM:  2.5     16.7          2.5 + 10 mM dimethyl-glutamate
PDH E1α-
p-Ser 293
total
E
B
glc, mM:  2.5    16.7    2.5     16.7
5 mM DCA
PDH E1α-
p-Ser 293
total
F
rtn, min:   0        4         0         2          4      10         0           0
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Fig. 2. PDH E1α phosphorylation/dephosphorylation in INS-1E cells depends on pyruvate
dehydrogenase kinases and Ca2+-activated PDH phosphatase. INS-1E cells were
preincubated for 30 min in KRBH containing 2.5 mM glucose and then stimulated as indi-
cated in the ﬁgures. The cell lysates (50 μg) were analysed with the antibody recognizing
site 1 phosphorylated PDH E1α (p-Ser293) (upper panels) and re-probed with an antibody
raised against total PDH E1α (lower panels). (A) Stimulation of INS-1E cells with 16.7 mM
glucose and either EGTA (1 mM) or KCl (30 mM). (B) Cells were incubated for 15 minwith
KRBH containing glucose as shown in the ﬁgure, followed by the addition of rotenone (rtn,
5 μM) for the indicated time. (C, D, E) INS-1E cells were incubated in KRBH containing
different secretagogues as shown in the ﬁgures. (F) INS-1E cells were preincubated for
30 min in KRBH containing 2.5 mM glucose or KRBH containing 2.5 mM glucose+5 mM
DCA. The cells were then incubated for 15 min in KRBH containing 2.5 or 16.7 mM glucose
with or without 5 mM DCA as indicated.
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those necessary to induce GSIS.
Acute glucose-dependent phosphorylation of E1α was also observed
in cultured rat islets (Fig. 1D). Glucose-dependent phosphorylation of
PDH therefore occurs both in INS-1E and primary β-cells.
3.2. Ca2+ stimulates PDH E1α dephosphorylation in INS-1E cells
The aboveﬁndings are counterintuitive as themitochondrial Ca2+ rise
associated with glucose stimulation in the β-cell would be expected to
cause dephosphorylation and activation of PDH [20,33]. To assess wheth-
er Ca2+promotes PDHdephosphorylation as observed in other cell types,
wemanipulated the glucose-associated Ca2+ rise. Removal of extracellu-
lar Ca2+ using EGTA abolishes both cytosolic and mitochondrial Ca2+
transients [20,34]. Suppression of Ca2+ signals with EGTA resulted in
glucose-dependent PDH E1α phosphorylation, which was much more
pronounced than with 16.7 mM glucose alone (Fig. 2A). Conversely,
when voltage-dependent Ca2+ inﬂux was potentiated by depolarizing
the plasma membrane using 30 mM KCl, glucose-induced phosphoryla-
tion was fully suppressed (Fig. 2A). Under resting conditions, raising or
suppressing Ca2+ signals did not alter PDH E1α phosphorylation (data
not shown). The results demonstrate that in INS-1E cells, Ca2+ activates
PDP similar to ﬁndings in other cell types. However, under physiological
conditions, glucose shifts the equilibrium towards phosphorylation
despite simultaneous Ca2+-activated dephosphorylation.
In addition to Ca2+, matrix metabolites are known to control PDH
activity. For instance a high ratio of NADH/NAD+, such as observed
after glucose stimulation, inhibits PDH activity. We therefore tested
whether increasing NADH levels alone could mimic glucose-induced
PDH E1α phosphorylation. The complex I inhibitor rotenone was
used to rapidly raise matrix NADH but this manipulation failed to
inﬂuence PDH phosphorylation at either low (2.5 mM) or intermedi-
ate (7 mM) glucose concentrations (Fig. 2B).
3.3. Alternative nutrient secretagogues do not induce PDH phosphorylation
Glucose may share some but not all downstream metabolites with
other nutrient secretagogues. Leucine and monomethyl succinate for
instance bypass glycolysis and do not depend on PDH activity for their
metabolism. Leucine provides mitochondrial acetyl-CoA as a sub-
strate for the TCA cycle while monomethyl succinate principally
stimulates oxygen consumption as a direct substrate of complex II
of the respiratory chain. Both secretagogues increase mitochondrial
ATP synthesis, accelerate respiration and raise mitochondrial matrix
Ca2+ similar to glucose [31,35,36]. Nevertheless, both leucine and
monomethyl succinate failed to induce PDH E1α phosphorylation
(Fig. 2C, D). Phosphorylation of PDH E1α is thus speciﬁcally linked
to metabolites/downstream signals resulting from glucose stimula-
tion. We tested glutamate, one such metabolite, the level of which
increases following glucose but not leucine stimulation [13,36,37].
As exogenous glutamate is not efﬁciently taken up by the cells, we
used the membrane-permeable compound dimethyl glutamate
(10 mM). Dimethyl glutamate was able to induce weak PDH E1α
phosphorylation albeit with a much slower time-course than glucose
(Fig. 2E). Therefore, it is unlikely that glutamate is the principle
mediator of glucose-induced PDH E1α phosphorylation.
3.4. PDK isoforms are required for glucose-induced PDH phosphorylation
in β-cells
Dichloroacetate (DCA), a general inhibitor of PDKs, prevented
glucose-induced PDH E1α Ser293 phosphorylation (Fig. 2F). In order
to identify the PDK isoform responsible for glucose-induced PDH
phosphorylation, we ﬁrst measured the expression of different
isoforms: PDK1, PDK2, PDK3 and PDK4. mRNA levels in rat islets,
puriﬁed β-cells and INS-1E cells were compared to puriﬁed α-cellsand a panel of rat tissues by quantitative RT-PCR (Fig. 3A–D). PDK1
expression in β- or INS-1E cells was comparable to most tissues test-
ed (Fig. 3A) but about 10-fold lower than in the heart, which is known
to express high levels of this isoform [38]. Weak expression of PDK2
mRNA was observed in both β- and INS-1E cells (more than 10
times lower than in highly expressing tissues such as kidney, brain
and heart; Fig. 3B). PDK3, on the other hand, was well expressed in
islet α- and β-cells as well as INS-1E cells. PDK3 expression levels
were more than 10 times higher than in poorly expressing tissues
such as liver and heart (Fig. 3C). In contrast, PDK4 expression was
almost undetectable in INS-1E cells but expressed in α-cells and in-
tact islets (Fig. 3D). In puriﬁed primary β-cells, expression was
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Fig. 3. Expression of PDK isoforms in INS-1E and islet α- and β-cells. PDK1 (A), PDK2 (B), PDK3 (C) and PDK4 (D) transcript levels were measured by quantitative RT-PCR and
normalised to cyclophilin (INS-1E cells, α- and β-cells, and several rat tissues) or RPS-29 (muscle and heart). Expression levels are shown relative to INS-1E cells (A, B, C) or
heart (D). The RNA was isolated from tissues obtained from two animals. RNA from α- and β-cells was obtained after FACS sorting of islets (3 independent isolations). Values rep-
resent the mean of four measurements +/−SEM. (E) Expression of PDK isoforms in INS-1E cells during acute glucose stimulation. Cells were preincubated for 30 min in KRBH
containing 2.5 mM glucose (white bars). The cells were then either maintained in 2.5 mM glucose (pale grey bars as indicated) or switched to 16.7 mM glucose for 10 or
30 min (dark grey respectively black bars). Shown are average CT-values determined by quantitative RT-PCR for PDK1, 2 and 3 from three independent experiments performed
in triplicate (N=3; +/−SEM). For PDK4, all CT-values were very high (above 38) and for most measurements PDK4 was undetectable independent of the glucose concentration.
The CT-values for PDK1-4 were determined under conditions matching those described in Fig. 1A (0, 10 and 30 min). Glucose did not signiﬁcantly change PDK expression.
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from contaminating non-β-cells.
PDK expression can be regulated by factors such as growth and
nutrient conditions [17,18]. For direct comparison, expression of
PDKs in INS-1E cells was thus also studied under conditions matching
those shown in Fig. 1A. RNA was isolated from INS-1E cells
preincubated in KRBH 2.5 mM glucose and increasing times at either
2.5 or 16.7 mM glucose. PDK1, 2 and 3 expression was unaffected in
response to acute glucose stimulation (Fig. 3E). The observed
glucose-induced phosphorylation of PDH is therefore not due to the
induction of PDK expression. PDK4 was not or only barely detectable
in all INS-1E cell samples studied. Based on this analysis, PDK4 is
unlikely to be of importance for PDH regulation in INS-1E cells.3.5. PDK1 and PDK3 phosphorylate PDH E1α in INS-1E cells
To test the contribution of the PDKs to glucose-induced PDH
phosphorylation in insulin secreting cells, we speciﬁcally knocked
down the expression of PDK isoforms. siRNAs designed to target
PDK1, PDK2 or PDK3 reduced the respective mRNA levels by 58.8%,
64.6% and 73.6% compared to control (Fig. 4A). The reduction of
individual PDKs neither resulted in the concomitant decrease nor a
compensatory increase in expression of the other PDK isoforms
(data not shown).
Knockdown of PDK1 or PDK3 led to a marked reduction of
glucose-dependent PDH E1α phosphorylation in INS-1E cells
(Fig. 4B). In comparison, lowering PDK2 had little or no effect on
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combinations of siRNAs showed that PDH E1α phosphorylation is
markedly decreased under all conditions where PDK1 or PDK3 are
knocked down (Fig. 4B). The results also demonstrate that lowering
of these PDKs cannot be compensated for by enhanced activity of
the other isoforms. Combining siRNAs against all three expressed
isoforms consistently resulted in the almost complete suppression
of PDH phosphorylation. Taken together, all three PDK isoforms
expressed in INS-1E cells contribute to glucose-induced PDH E1α
phosphorylation with PDK1 and PDK3 having the strongest impact.
3.6. PDH E1α phosphorylation does not affect glucose-stimulated insulin
secretion
Phosphorylation of PDHmay be inhibitory formetabolism-secretion
coupling as it attenuates pyruvate oxidation. Alternatively, PDH phos-
phorylation could stimulate metabolism-secretion coupling by favoring
anaplerosis and the generation of metabolic signals. Therefore we
followedmetabolism-secretion coupling after knockdown of individual
PDKs or a combination of PDK isoforms (Fig. 5A). Control INS-1E cells
exposed for 30 min to 16.7 mM glucose increased hormone secretion
3.1-fold compared to 2.5 mM glucose. Lowering the expression of the
PDK1, PDK2 or PDK3 did neither affect basal insulin secretion nor the
glucose-induced response. Glucose-stimulated insulin secretion was
even preserved under conditions that almost completely prevented
PDH phosphorylation, using siRNAs against PDK1 and PDK3 or siRNAs
against all three studied PDK isoforms (Fig. 5A). During GSIS cytosolic
Ca2+ rises are relayed intomitochondria. The Ca2+ rise in the organelle
can be used as a sensitive kinetic read-out of the underlying
metabolism-secretion coupling [20]. Glucose initiated a robust
mitochondrial Ca2+ response in control siRNA-treated INS-1E cells.
Down-regulation in combination of PDK1, PDK2 and PDK3 did neither
delay the time of onset nor the amplitude of the glucose-induced mito-
chondrial Ca2+ rise (Fig. 5B). Taken together, metabolism-secretioncoupling is normal under conditions that prevent glucose-induced
phosphorylation of PDH E1α in INS-1E cells.
3.7. Glucose-stimulated PDH E1α phosphorylation decreases PDH activity
Based on the preceding results, we assessed the effect of phosphor-
ylation on PDH activity. Enzyme activity was determined in extracts
from INS-1E cells maintained for 15 min in either resting (2.5 mM) or
stimulatory glucose (16.7 mM). Half of the sample was used to deter-
mine total PDH activity by treating the lysate with PDP1. Results are
expressed as percentage of total activity. At 2.5 mM glucose 91 % of
PDH was active consistent with the faint signal obtained using
phosphospeciﬁc PDH antibodies. Following stimulation with 16.7 mM
glucose PDH activity was reduced to 78% of total (Fig. 6A). The
remaining large fraction of active PDHmay leave pyruvate metabolism
close to normal thus not affectingmetabolism-secretion coupling under
our standard conditions. This was tested in intact cells measuring
[1-14C] pyruvate oxidation. Release of 14CO2 as PDH decarboxylates
[1-14C] pyruvate is an in situ read-out for PDH activity. INS-1E cells
were incubated in the presence of a constant amount of labeled and
cold pyruvate (0.1 mM). When INS-1E cells were incubated in
16.7 mM glucose, oxidation of labeled pyruvate was decreased by
~30% compared to the 2.5 mM glucose control (Fig. 6B).
Mechanistically, there are at least two possible ways to explain reduced
[1-14C] pyruvate oxidation: 1) PDH phosphorylation reduces pyruvate
oxidation as demonstrated in Fig. 6A. 2) Glucose metabolism forms
cold pyruvate to the extent that it competes with the constant amount
of labeled pyruvate added. To assess the contribution of PDH phosphor-
ylation on pyruvate ﬂux we therefore compared pyruvate oxidation
under identical conditions but after suppression of PDH phosphoryla-
tion using PDK siRNAs. For all conditions tested glucose lowered pyru-
vate oxidation (Fig. 6C). Interestingly, at 16.7 mM glucose pyruvate
oxidation was unaffected whether or not PDH phosphorylation was
suppressed by siRNAs against PDK1, PDK2 and PDK3 (Fig. 6C). Our
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glucose-induced phosphorylation but is still sufﬁcient to maintain nor-
mal pyruvate ﬂux. Under the conditions studied here, the observed PDH
E1α phosphorylation therefore does not impact on metabolism-
secretion coupling.
3.8. PDH E1α phosphorylation is not important for INS-1E cell viability
during glucotoxicity
Rather than playing an important role in acute glucose-stimulated
insulin secretion, PDH phosphorylation may be able to adapt β-cell
function to the average glucose availability. For instance, PDH phos-
phorylation may have some protective function when glucose
concentrations remain continuously high. In support of this possibili-
ty several PDK isoforms are upregulated in islet β-cells cultured under
glucotoxic conditions [18]. In agreement with these earlier ﬁndings,
we observed that PDH E1α phosphorylation in INS-1E cells was dra-
matically increased when the cells were cultured for 48 h in 30 mM
glucose (Fig. 7A) compared to culture in standard medium (11 mM
glucose). After lowering the glucose concentration in the medium to
4 mM for 2 h, PDH E1α phosphorylation was undetectable showing
that this glucose effect is reversible. Interestingly, INS-1E cellscultured for 2 days in 30 mM glucose medium demonstrated more
robust PDH E1α phosphorylation during acute glucose stimulation,
compared with cells cultured in 11 mM glucose (Fig. 7B). To elucidate
whether more robust glucose-induced PDH phosphorylation is due to
an elevated expression of PDKs in INS-1E cells, we cultured the cells
for 48 h in 11 respectively 30 mM glucose medium (condition as
described for Fig. 7A). However, the glucotoxic (30 mM glucose)
condition did not alter PDK 1–3 expression and PDK4 remained
barely detectable (Fig. 7C). Enhanced PDH phosphorylation in
INS-1E cells is not due to changes in PDK expression but likely due
to other adaptive changes.
Prolonged exposure of β-cells to elevated glucose involves activa-
tion of pro-apoptotic and lipogenic genes, resulting in increased lipid
accumulation, reduced GSIS and apoptosis [39,40]. Enhanced PDH
E1α phosphorylation, as observed here, should favor anaplerosis
resulting in the export of mitochondrial substrates for fatty acid
synthesis. This may reduce β-cell function and render them more
susceptible to cell death. We therefore tested whether control of
PDH activity by phosphorylation inﬂuenced apoptosis of INS-1E
cells exposed to glucotoxic conditions (48 h; 30 mM glucose). Consis-
tent with earlier results, cell death as assessed by the release of
histone-complexed DNA fragments (Fig. 7D) or the fraction of dead
cells (Fig. 7E; propidium iodide permeable cells; see Materials and
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30 mM glucose compared to control [40]. To test if PDH E1α phos-
phorylation affects cell viability, we compared cell death in INS-1E
cells treated with siRNAs against PDK1, PDK2 and PDK3 or control
siRNAs. Downregulation of the PDK isoforms did not signiﬁcantly
alter glucose-induced cell death (Fig. 7D, E). Therefore, regulation of
PDH activity does not alter the consequences of exposure to harmful
glucose concentrations.
4. Discussion
In the β-cell, PDH serves a regulatory function as its activity deter-
mines to what extent glucose-derived pyruvate enters the oxidative
or anaplerotic pathways. As both branches of metabolism are neces-
sary for GSIS, the impact of PDH regulation on metabolism-secretion
coupling is difﬁcult to predict. Unfortunately, there is a large discrep-
ancy between different publications concerning the fraction of active
PDH in β-cells. At sub-stimulatory glucose concentrations PDH activ-
ity in islets was found to be 5%, 16%, 40% or 94% of total [18,21–23].
Depending on the study, glucose thus caused no or very pronounced
activation of the enzyme.
Here we demonstrate that acute stimulation of rat islets or INS-1E
insulinoma cells with glucose elicits rapid phosphorylation of PDH
E1α. Under non-stimulatory conditions, however, PDHphosphorylation
was barely detectable. In addition, PDH activity in INS-1E cells was al-
most maximal (91% active) at resting glucose concentrations and was
reduced to 78% at a maximal stimulatory concentration. Moreover, ourresults were consistent using two independent methods. Our ﬁndings
are in agreement with 13C-NMR experiments that observed elevated
anaplerotic ﬂux following glucose stimulation [10,41] as inhibition of
PDH by phosphorylation should favor carboxylation of pyruvate by PC.
Nevertheless, glucose-dependent phosphorylation of PDHwas un-
expected. The well described glucose-induced mitochondrial Ca2+
rise should activate PDP1 and therefore favor PDH dephosphoryla-
tion. We show in intact cells that elevation of mitochondrial Ca2+ in-
deed favors dephosphorylation of PDH E1α.
For each nutrient condition a balance may exist between PDH E1α
phosphorylation and dephosphorylation. Reciprocal regulation of
PDK and PDP activities has already been reported for instance in rat
heart and kidney [42]. As glucose raises matrix Ca2+ and therefore
stimulates PDP activity, net phosphorylation of PDH E1α can only
be explained if activation of PDK is more pronounced than stimula-
tion of PDP. Such stimulation of PDK is likely due to signals linked
to glucose metabolism. For example, the NADH/NAD+, acetyl-CoA/
CoA and ATP/ADP ratios, which rapidly increase following glucose
stimulation of β-cells [43,44], are known to activate PDK [45]. Howev-
er, artiﬁcially raising the mitochondrial NADH/NAD+ ratio using the
complex I inhibitor rotenone did not promote PDH E1α phosphoryla-
tion. The changes required to induce PDH E1α phosphorylation by
glucose therefore must be the consequence of the combination of
several PDK activators.
Glucose also gives rise to the PDK inhibitor pyruvate, which in-
creases several fold during glucose stimulation of INS-1 cells [46].
INS-1E cells, unlike primary β-cells, express the monocarboxylate
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[47]. Nevertheless, pyruvate failed to cause phosphorylation of PDH
E1α (data not shown). Under these conditions, intramitochondrial py-
ruvate may reach sufﬁciently high concentrations to inhibit PDKs.
Phosphorylation of PDH E1α during glucose stimulation is consistent
with the concept that PDH activity is inhibitedwhen energy is abundant
(high ATP/ADP ratio) and consequently the rate of glucose oxidation
should be reduced. It was therefore very surprising that other secreta-
gogues such as leucine and monomethyl succinate, did not cause PDH
E1α phosphorylation. These nutrients bypass glycolysis and PDH but
their effects onmitochondrial oxidativemetabolism, respiration andmi-
tochondrial signals resemble many of the changes elicited by glucose. A
search for candidate metabolites required for glucose-induced PDH E1α
phosphorylation will have to focus on metabolites speciﬁcally linked to
glucosemetabolism. One suchmetabolite is glutamate [13,36,46], which
we tested using themembrane-permeable dimethyl glutamate. Howev-
er, intracellular glutamate caused only weak phosphorylation of PDH
E1α over a time-course much slower than glucose-induced phosphory-
lation. Thus, the glucose effect cannot solely be mediated by glutamate.
It may be speculated that in order to cause PDH E1α phosphorylation a
nutrient must fulﬁll at least two requirements. First, it should raise the
metabolite ratios that activate PDKs and second, provide the substrate
pyruvate. We speculate that in situ activated PDKs only recognise and
therefore phosphorylate PDH which is actively turning over its sub-
strate. These two criteria are onlymet by glucose but not nutrient secre-
tagogues that bypass glycolysis.
PDH E1α phosphorylation was prevented by the pyruvate ana-
logue DCA demonstrating that glucose acts through the activation of
PDKs. We examined the expression of PDKs in INS-1E cells, puriﬁed
β- and α-cells as well as intact rat islets. In agreement with earlier
studies we detected expression of PDK1, PDK2 and PDK4 in intact is-
lets [48]. Through the study of puriﬁed islet cells we ﬁnd PDK4 to be
preferentially expressed in α-cells. PDK4 was close to undetectable
in INS-1E cells. The low level of PDK4 expression in β-cells may there-
fore be due to contaminating non-β cells. These results are supported
by expression proﬁling in β-cells obtained after laser capture, inwhich
PDK4 expression was not detected [49]. Surprisingly, we ﬁnd robust
expression of PDK3 in rat β-cells, while this isoform was not detected
inmouse islets [18]. In support of our expression data, PDK3 like PDK1
strongly contributes to glucose-induced phosphorylation of PDH E1α,
while the contribution of PDK2 was only modest.
Suppression of PDK1 has recently been found to enhance GSIS
[26]. Our prediction therefore was that PDH phosphorylation limits
the acute glucose response. Alternatively, we could have expected
that phosphorylation plays a role in accelerating anaplerosis and if
prevented would lower ampliﬁcation of insulin secretion. Preventing
glucose-induced PDH phosphorylation did not affect insulin secretion
even when siRNAs against PDK 1, 2 and 3 were combined. Our results
therefore are in agreement with a study over-expressing the catalytic
subunit of PDP in β-cell mitochondria, which did not result in changes
in metabolism-secretion coupling [23].
Under the conditions studied here, PDH activity was reduced
from 91% to 78% of total during the shift from low to stimulatory glu-
cose, which did not impact on GSIS. Our experiments also show that
oxidation of [1-14C] pyruvate is reduced by 30% when cells are
shifted to high glucose, which agrees with glucose-induced PDH
phosphorylation. Using siRNAs against PDK1, PDK2 and PDK3 we
ﬁnd that glucose still lowered oxidation of [1-14C] pyruvate in intact
cells. We conclude that reduced oxidation of the labeled pyruvate oc-
curs as it competes with cold pyruvate derived from glucose. Flux of
pyruvate through the oxidative pathway is not lowered when the
cells are stimulated by glucose despite the small reduction of PDH
activity.
It is possible that PDH expression in INS-1E cells is in excess and
therefore lowering its activity is of little consequence. Alternatively,
reduced PDH activity may elevate the concentration of mitochondrialpyruvate to the point where pyruvate oxidation matches the rate
observed in control cells. Liu and colleagues have proposed a similar
mechanism to explain normal oxidative metabolism in β-cells with
impaired PDH function [24].
It is noteworthy that islets from the β-cell-speciﬁc PDH (Pdha1)
knockout mouse still respond to glucose albeit with a lower fold
change than controls [8]. Alternative pathways may take over in the
mutant mice. The here observed PDH phosphorylation by glucose
may protect from excessive glucose oxidation while having little im-
pact on the acute regulation of GSIS.
In summary, our measurements demonstrate that in INS-1E cells
PDH is almost maximally active and partially inhibited when stimu-
lated with glucose. This effect is speciﬁc for the hexose as it was not
observed with other nutrient secretagogues. The here described
glucose-induced phosphorylation (inhibition) of PDH is not sufﬁcient
to slow pyruvate ﬂux nor does it alter metabolism-secretion coupling
in INS-1E clonal β-cells.
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